PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50125C00005Overall objective of THIS contract IS — Flugen Inc

Flugen Inc holds $742K across 1 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Feb 28, 2027 PoP end — agencies typically plan 12–18 months ahead.

Barda - Aspr / Daappo / Barda Dcma

Awarding office

Flugen Inc

Recipient

Feb 28, 2027

PoP end

$742K

Obligated

$742K

Potential

541714

NAICS

AN12

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Flugen Inc — $90

Contract facts

NONE

Contract number75A50125C00005

AgencyBarda - Aspr / Daappo / Barda Dcma

Awarding officeBarda - Aspr / Daappo / Barda Dcma

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentFlugen Inc

CAGE54YS4

UEIM9FHAR3RBML5

NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN12

Place of performanceMADISON WI

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startJul 25, 2025

PoP end (current)Feb 28, 2027

Obligated$742K

Current value$742K

Potential value$742K

THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO IDENTIFY HUMORAL CORRELATES OF PROTECTION FOLLOWING H3N2 M2SR VACCINATION, SUPPORTING THE CLINICAL DEVELOPMENT OF M2SR AS A STRATEGY TO INDUCE BOTH SEASONAL INFLUENZA IMMUNITY AND PRE-PANDEMIC PROTECTION A is a federal NONE award for Barda - Aspr / Daappo / Barda Dcma held by Flugen Inc. Estimated value $742K ($742K obligated). Current period of performance ends Feb 28, 2027. Last award drew 1 bidder. Place of performance: MADISON WI.

Recompete timing

Public

● Expiring in 174 days

Current PoP ends Feb 28, 2027 (174 days remaining). Agencies typically plan 12–18 months ahead — at 5.7 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Flugen Inc — $742K obligated across 1 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$742K · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75A50125C00005?

75A50125C00005 (Overall objective of THIS contract IS) is a Barda - Aspr / Daappo / Barda Dcma award with a potential value of $742K, currently held by Flugen Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50125C00005?

Barda - Aspr / Daappo / Barda Dcma awarded 75A50125C00005 to Flugen Inc (potential $742K).

Who is the incumbent on 75A50125C00005?

Flugen Inc is the incumbent with $742K across 1 related awards in SCOUT’s public footprint. The current period of performance ends Feb 28, 2027.

When does Flugen Inc’s 75A50125C00005 come up for recompete?

SCOUT tracks a period-of-performance end of Feb 28, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75A50125C00005 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 25, 2026 · refreshed monthlyLatest procurement action Feb 2, 2026